On the public citation graph

Advanced human iPSC-based preclinical model for Parkinson’s disease with optogenetic alpha-synuclein aggregation

https://doi.org/10.1016/j.stem.2023.05.015

0 signed · 148 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/stem.3163openalex-snapshot

Generation of homogeneous midbrain organoids with in vivo-like cellular composition facilitates neurotoxin-based Parkinson's disease modeling

inferredcites →https://doi.org/10.1007/s00401-012-0964-xopenalex-snapshot

An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology

inferredcites →https://doi.org/10.1007/s00401-016-1648-8openalex-snapshot

Toll-like receptor 2 is increased in neurons in Parkinson’s disease brain and may contribute to alpha-synuclein pathology

inferredcites →https://doi.org/10.1007/s00401-019-01995-0openalex-snapshot

LRRK2 modifies α-syn pathology and spread in mouse models and human neurons

inferredcites →https://doi.org/10.1007/s12035-018-0923-1openalex-snapshot

Cilostazol Mediated Nurr1 and Autophagy Enhancement: Neuroprotective Activity in Rat Rotenone PD Model

inferredcites →https://doi.org/10.1007/s12640-017-9825-7openalex-snapshot

Dexamethasone Inhibits Copper-Induced Alpha-Synuclein Aggregation by a Metallothionein-Dependent Mechanism

inferredcites →https://doi.org/10.1016/j.brainres.2015.11.013openalex-snapshot

Back and forth in time: Directing age in iPSC-derived lineages

inferredcites →https://doi.org/10.1016/j.ceb.2012.08.014openalex-snapshot

iPSC technology to study human aging and aging-related disorders

inferredcites →https://doi.org/10.1016/j.cell.2013.05.057openalex-snapshot

Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons

inferredcites →https://doi.org/10.1016/j.cell.2016.04.032openalex-snapshot

Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure

inferredcites →https://doi.org/10.1016/j.celrep.2014.10.023openalex-snapshot

iPSC-Derived Dopamine Neurons Reveal Differences between Monozygotic Twins Discordant for Parkinson’s Disease

inferredcites →https://doi.org/10.1016/j.chembiol.2014.05.013openalex-snapshot

Spatiotemporal Control of Fibroblast Growth Factor Receptor Signals by Blue Light

inferredcites →https://doi.org/10.1016/j.nbd.2014.05.020openalex-snapshot

Intracellular processing of disease-associated α-synuclein in the human brain suggests prion-like cell-to-cell spread

inferredcites →https://doi.org/10.1016/j.nbd.2019.104525openalex-snapshot

Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils

inferredcites →https://doi.org/10.1016/j.neuron.2006.09.026openalex-snapshot

Mechanisms of Parkinson's Disease Linked to Pathological α-Synuclein: New Targets for Drug Discovery

inferredcites →https://doi.org/10.1016/j.neuron.2011.08.033openalex-snapshot

Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death

inferredcites →https://doi.org/10.1016/j.neuron.2017.09.047openalex-snapshot

Optogenetic Tools for Subcellular Applications in Neuroscience

inferredcites →https://doi.org/10.1016/j.neuron.2019.05.035openalex-snapshot

Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson’s Disease

inferredcites →https://doi.org/10.1016/j.neuron.2021.09.031openalex-snapshot

TRIP12 ubiquitination of glucocerebrosidase contributes to neurodegeneration in Parkinson’s disease

inferredcites →https://doi.org/10.1016/j.stem.2013.11.006openalex-snapshot

Human iPSC-Based Modeling of Late-Onset Disease via Progerin-Induced Aging

inferredcites →https://doi.org/10.1016/j.stem.2016.05.022openalex-snapshot

Stem Cell Models of Human Brain Development

inferredcites →https://doi.org/10.1016/j.stem.2016.07.005openalex-snapshot

Midbrain-like Organoids from Human Pluripotent Stem Cells Contain Functional Dopaminergic and Neuromelanin-Producing Neurons

inferredcites →https://doi.org/10.1016/j.stem.2019.08.013openalex-snapshot

Loss of SATB1 Induces p21-Dependent Cellular Senescence in Post-mitotic Dopaminergic Neurons

inferredcites →https://doi.org/10.1016/j.stem.2020.08.002openalex-snapshot

Defects in mRNA Translation in LRRK2-Mutant hiPSC-Derived Dopaminergic Neurons Lead to Dysregulated Calcium Homeostasis

inferredcites →https://doi.org/10.1016/s0197-4580(02)00065-9openalex-snapshot

Staging of brain pathology related to sporadic Parkinson’s disease

inferredcites →https://doi.org/10.1016/s0896-6273(02)00682-7openalex-snapshot

Neuronal α-Synucleinopathy with Severe Movement Disorder in Mice Expressing A53T Human α-Synuclein

inferredcites →https://doi.org/10.1016/s0896-6273(03)00568-3openalex-snapshot

Parkinson's Disease

inferredcites →https://doi.org/10.1038/42166openalex-snapshot

α-Synuclein in Lewy bodies

inferredcites →https://doi.org/10.1038/emboj.2012.170openalex-snapshot

Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences

inferredcites →https://doi.org/10.1038/nature10648openalex-snapshot

Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s disease

inferredcites →https://doi.org/10.1038/ncb2763openalex-snapshot

Signal integration by mTORC1 coordinates nutrient input with biosynthetic output

inferredcites →https://doi.org/10.1038/ncomms1453openalex-snapshot

Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus

inferredcites →https://doi.org/10.1038/nm.4269openalex-snapshot

α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies

inferredcites →https://doi.org/10.1038/nm1747openalex-snapshot

Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease

inferredcites →https://doi.org/10.1038/nmeth.2089openalex-snapshot

NIH Image to ImageJ: 25 years of image analysis

inferredcites →https://doi.org/10.1038/nn1443openalex-snapshot

α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease

inferredcites →https://doi.org/10.1038/nrm3025openalex-snapshot

mTOR: from growth signal integration to cancer, diabetes and ageing

inferredcites →https://doi.org/10.1038/s41467-017-00060-2openalex-snapshot

Optogenetic protein clustering through fluorescent protein tagging and extension of CRY2

inferredcites →https://doi.org/10.1038/s41593-019-0457-5openalex-snapshot

Spread of α-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis

inferredcites →https://doi.org/10.1038/s41598-017-05633-1openalex-snapshot

Expansion of human midbrain floor plate progenitors from induced pluripotent stem cells increases dopaminergic neuron differentiation potential

inferredcites →https://doi.org/10.1038/srep05797openalex-snapshot

Quantitative Measurement of Intact Alpha-Synuclein Proteoforms from Post-Mortem Control and Parkinson's Disease Brain Tissue by Intact Protein Mass Spectrometry

inferredcites →https://doi.org/10.1073/pnas.0908005106openalex-snapshot

Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells

inferredcites →https://doi.org/10.1073/pnas.1100976108openalex-snapshot

In vivo demonstration that α-synuclein oligomers are toxic

inferredcites →https://doi.org/10.1073/pnas.1710442114openalex-snapshot

Modeling Parkinson’s disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain

inferredcites →https://doi.org/10.1073/pnas.1913904117openalex-snapshot

The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration

inferredcites →https://doi.org/10.1073/pnas.95.7.4013openalex-snapshot

Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons

inferredcites →https://doi.org/10.1074/jbc.m105326200openalex-snapshot

Formation and Removal of α-Synuclein Aggregates in Cells Exposed to Mitochondrial Inhibitors

inferredcites →https://doi.org/10.1074/jbc.m300227200openalex-snapshot

α-Synuclein Is Degraded by Both Autophagy and the Proteasome

inferredcites →https://doi.org/10.1074/jbc.m508361200openalex-snapshot

mTOR·RICTOR Is the Ser473 Kinase for Akt/Protein Kinase B in 3T3-L1 Adipocytes

inferredcites →https://doi.org/10.1083/jcb.200907014openalex-snapshot

Coordination of membrane events during autophagy by multiple class III PI3-kinase complexes

inferredcites →https://doi.org/10.1093/brain/awm302openalex-snapshot

Axonal -synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease

inferredcites →https://doi.org/10.1093/hmg/ddt674openalex-snapshot

c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's disease

inferredcites →https://doi.org/10.1093/jnen/62.12.1241openalex-snapshot

Morphogenesis of Lewy Bodies: Dissimilar Incorporation of α-Synuclein, Ubiquitin, and p62

inferredcites →https://doi.org/10.1093/jnen/74.12.1158openalex-snapshot

Transmission of Soluble and Insoluble α-Synuclein to Mice

inferredcites →https://doi.org/10.1111/aor.14503openalex-snapshot

FDA Modernization Act 2.0 allows for alternatives to animal testing

inferredcites →https://doi.org/10.1111/j.1349-7006.2008.00891.xopenalex-snapshot

Phosphatidylinositol 3‐kinase inhibitors: promising drug candidates for cancer therapy

inferredcites →https://doi.org/10.1111/j.1750-3639.2008.00140.xopenalex-snapshot

Three‐Layered Structure Shared Between Lewy Bodies and Lewy Neurites—Three‐Dimensional Reconstruction of Triple‐Labeled Sections

inferredcites →https://doi.org/10.1111/jnc.13731openalex-snapshot

Mitochondrial dysfunction in Parkinson's disease

inferredcites →https://doi.org/10.1111/jnc.14806openalex-snapshot

Cellular models of alpha‐synuclein toxicity and aggregation

inferredcites →https://doi.org/10.1126/science.1090278openalex-snapshot

α-Synuclein Locus Triplication Causes Parkinson's Disease

inferredcites →https://doi.org/10.1126/science.1101738openalex-snapshot

Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy

inferredcites →https://doi.org/10.1126/science.1227157openalex-snapshot

Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice

inferredcites →https://doi.org/10.1126/science.276.5321.2045openalex-snapshot

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

inferredcites →https://doi.org/10.1126/science.290.5497.1717openalex-snapshot

Autophagy as a Regulated Pathway of Cellular Degradation

inferredcites →https://doi.org/10.1126/science.adg6276openalex-snapshot

FDA no longer has to require animal testing for new drugs

inferredcites →https://doi.org/10.1146/annurev.neuro.22.1.123openalex-snapshot

ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE

inferredcites →https://doi.org/10.1155/2015/628192openalex-snapshot

Insights into Neuroinflammation in Parkinson’s Disease: From Biomarkers to Anti-Inflammatory Based Therapies

inferredcites →https://doi.org/10.1158/0008-5472.can-08-1385openalex-snapshot

NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations

inferredcites →https://doi.org/10.1158/2159-8290.cd-15-0460openalex-snapshot

PtdIns(3,4,5) P 3-Dependent Activation of the mTORC2 Kinase Complex

inferredcites →https://doi.org/10.1159/000373980openalex-snapshot

Repertoires of Autophagy in the Pathogenesis of Ocular Diseases

inferredcites →https://doi.org/10.1177/108705719900400206openalex-snapshot

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

inferredcites →https://doi.org/10.1186/s12974-019-1646-6openalex-snapshot

CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease

inferredcites →https://doi.org/10.1186/s13024-016-0072-9openalex-snapshot

Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease

inferredcites →https://doi.org/10.14802/jmd.19046openalex-snapshot

Modeling α-Synuclein Propagation with Preformed Fibril Injections

inferredcites →https://doi.org/10.14802/jmd.19046.eopenalex-snapshot

Modeling α-Synuclein Propagation with Preformed Fibril Injections

inferredcites →https://doi.org/10.1523/jneurosci.4658-15.2016openalex-snapshot

Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration

inferredcites →https://doi.org/10.31887/dcns.2004.6.3/ahartmannopenalex-snapshot

Postmortem studies in Parkinson's disease

inferredcites →https://doi.org/10.3389/fneur.2019.00035openalex-snapshot

Association of Two Polymorphisms in CCL2 With Parkinson's Disease: A Case-Control Study

inferredcites →https://doi.org/10.3389/fnmol.2019.00299openalex-snapshot

Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease

inferredcites →https://doi.org/10.3791/53193openalex-snapshot

Differentiation of the SH-SY5Y Human Neuroblastoma Cell Line

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4818803openalex-extracted

Roles of Ipsc in Advancing Treatments for Neurological Disorders

inferred← citeshttps://doi.org/10.1002/adhm.202303041openalex-snapshot

Precision Medicine in Parkinson's Disease Using Induced Pluripotent Stem Cells

inferred← citeshttps://doi.org/10.1002/advs.202501694openalex-snapshot

Extracellular LCN2 Binding to 24p3R in Astrocytes Impedes α‐Synuclein Endocytosis in Parkinson's Disease

inferred← citeshttps://doi.org/10.1002/advs.202510641openalex-snapshot

Temporal Transcriptional Regulation of Human Neuronal Differentiation via Forward Programming

inferred← citeshttps://doi.org/10.1002/advs.78007openalex-snapshot

Developmentally Guided Differentiation of Ventral Midbrain Dopaminergic Cells Validated in Proteopathy‐Based Parkinson's Disease Models

inferred← citeshttps://doi.org/10.1002/agm2.70099openalex-snapshot

Shared Metabolic–Proteinopathy Axis in Alzheimer's Disease and Parkinson's Disease: Evidence for a Convergent but Not Identical Disease Spectrum

inferred← citeshttps://doi.org/10.1002/mco2.70575openalex-snapshot

Organoids in Cancer Research and Regenerative Medicine: Current Status, Challenges, and Future Prospects

inferred← citeshttps://doi.org/10.1002/med.70080openalex-snapshot

α‐Synuclein Seeds Amplification Assays for Parkinson's Disease and Related Synucleinopathies

inferred← citeshttps://doi.org/10.1002/tcr.202300282openalex-snapshot

Navigating α‐Synuclein Aggregation Inhibition: Methods, Mechanisms, and Molecular Targets

inferred← citeshttps://doi.org/10.1007/s11033-025-10463-wopenalex-snapshot

Molecular mechanisms and biomarkers in neurodegenerative disorders: a comprehensive review

inferred← citeshttps://doi.org/10.1007/s12035-026-06048-8openalex-snapshot

Curcumin Attenuates Cuproptosis via Activating Autophagy Through Inhibition of the AKT/mTOR/P70S6K-Signaling Pathway in Parkinson’s Disease Models

inferred← citeshttps://doi.org/10.1007/s12035-026-06248-2openalex-snapshot

A Live-Cell Imaging System for the Identification of Pro- and Anti-Aggregatory α-Synuclein Modulators

inferred← citeshttps://doi.org/10.1007/s12640-026-00825-yopenalex-snapshot

Atorvastatin Shows Limited Disease-Modifying Effects in an A53T α-Synuclein Mouse Model of Parkinson’s Disease

inferred← citeshttps://doi.org/10.1016/j.arr.2024.102517openalex-snapshot

Advances in human cellular mechanistic understanding and drug discovery of brain organoids for neurodegenerative diseases

inferred← citeshttps://doi.org/10.1016/j.arr.2025.102851openalex-snapshot

Next-generation CRISPR gene editing tools in the precision treatment of Alzheimer’s and Parkinson’s disease

inferred← citeshttps://doi.org/10.1016/j.biopha.2025.118802openalex-snapshot

Binding domains of α-synuclein receptors with monomeric/oligomeric α-synuclein: Implications for Parkinson’s disease

inferred← citeshttps://doi.org/10.1016/j.biotechadv.2025.108761openalex-snapshot

Capitalizing on mechanistic insights to power design of future-ready intracellular optogenetics tools

inferred← citeshttps://doi.org/10.1016/j.brainres.2025.150002openalex-snapshot

The traffic jam hypothesis: Unravelling cellular dysfunctions in Parkinsonism diseases

inferred← citeshttps://doi.org/10.1016/j.brainresbull.2024.111024openalex-snapshot

Advances in animal models of Parkinson's disease

inferred← citeshttps://doi.org/10.1016/j.cell.2026.02.012openalex-snapshot

New approach methodologies for drug discovery

inferred← citeshttps://doi.org/10.1016/j.copbio.2024.103126openalex-snapshot

Lighting the way: recent developments and applications in molecular optogenetics

inferred← citeshttps://doi.org/10.1016/j.copbio.2024.103253openalex-snapshot

Engineering organoids as cerebral disease models

inferred← citeshttps://doi.org/10.1016/j.csbj.2025.02.014openalex-snapshot

Protein design accelerates the development and application of optogenetic tools

inferred← citeshttps://doi.org/10.1016/j.drudis.2026.104742openalex-snapshot

Brain organoids in Parkinson’s disease drug development: Human-specific models for translational discovery

inferred← citeshttps://doi.org/10.1016/j.expneurol.2026.116022openalex-snapshot

Midbrain organoids as next-generation models for Parkinson's disease: From pathogenesis to therapeutic discovery

inferred← citeshttps://doi.org/10.1016/j.jneumeth.2025.110614openalex-snapshot

Development and evaluation of a 3D-engineered neural co-culture system: Impacts on oxidative stress, pentose phosphate pathway, trace element and mineral metabolisms

inferred← citeshttps://doi.org/10.1016/j.mocell.2025.100247openalex-snapshot

Optogenetics to biomolecular phase separation in neurodegenerative diseases

inferred← citeshttps://doi.org/10.1016/j.mocell.2025.100284openalex-snapshot

Dual SMAD inhibition as a versatile platform in human pluripotent stem cell–based regenerative medicine and disease modeling

inferred← citeshttps://doi.org/10.1016/j.neuropharm.2026.111185openalex-snapshot

Opto-CRISPR technologies in translational neuropharmacology

inferred← citeshttps://doi.org/10.1016/j.nsa.2026.106988openalex-snapshot

Differentiation of human iPSCs into dopaminergic neurons: comparative analysis of 2D and 3D protocols for disease modeling and pharmacology

inferred← citeshttps://doi.org/10.1016/j.prp.2024.155511openalex-snapshot

Non-coding RNAs in Parkinson's disease: Regulating SNCA and alpha-synuclein aggregation

inferred← citeshttps://doi.org/10.1016/j.tibtech.2025.02.009openalex-snapshot

Brain organoids: building higher-order complexity and neural circuitry models

inferred← citeshttps://doi.org/10.1016/j.xpro.2023.102609openalex-snapshot

Optogenetic induction of alpha-synuclein aggregation in human dopaminergic neurons to model Parkinson’s disease pathology

inferred← citeshttps://doi.org/10.1038/s12276-026-01679-2openalex-snapshot

Human pluripotent stem cell engineering with CRISPR–Cas9 for Parkinson’s disease

inferred← citeshttps://doi.org/10.1038/s41467-026-71112-9openalex-snapshot

Modelling synaptic dysfunction in childhood dementia using human iPSC-derived cortical networks

inferred← citeshttps://doi.org/10.1038/s41531-024-00799-8openalex-snapshot

Human midbrain organoids: a powerful tool for advanced Parkinson’s disease modeling and therapy exploration

inferred← citeshttps://doi.org/10.1038/s41531-025-01137-2openalex-snapshot

Investigating the ageing-Parkinson’s disease nexus: standardisation of in vitro models and techniques by the PD-AGE network

inferred← citeshttps://doi.org/10.1038/s42003-025-08854-7openalex-snapshot

HSPA4 restrains transferrin in dopaminergic neurons to attenuate ferroptosis in a Parkinson’s disease model

inferred← citeshttps://doi.org/10.1101/2024.09.24.613225openalex-snapshot

Brainwaves Monitoring via Human Midbrain Organoids Microphysiological Analysis Platform: MAP

inferred← citeshttps://doi.org/10.1101/2025.10.26.684610openalex-snapshot

Recapitulating Parkinson’s pathology in human iPSC dopaminergic neurons reveals new mechanistic insights into Lewy body formation and heterogeneity

inferred← citeshttps://doi.org/10.1126/sciadv.aed8851openalex-snapshot

Modeling Parkinson’s pathology in human iPSC dopaminergic neurons uncovers key mechanisms of Lewy body formation and heterogeneity

inferred← citeshttps://doi.org/10.1186/s12964-025-02461-zopenalex-snapshot

Bridging the gap in Parkinson’s disease research: from general pathophysiology to advanced 3d cell culture models

inferred← citeshttps://doi.org/10.1186/s12964-026-03197-0openalex-snapshot

Beyond phenotypic markers: rethinking dopaminergic identity in iPSC-derived neurons

inferred← citeshttps://doi.org/10.1186/s13287-025-04285-7openalex-snapshot

Cell-based regenerative and rejuvenation strategies for treating neurodegenerative diseases

inferred← citeshttps://doi.org/10.1186/s13287-025-04660-4openalex-snapshot

Three-dimensional midbrain organoids: a next-generation tool for Parkinson’s disease modelling and drug discovery

inferred← citeshttps://doi.org/10.1186/s13619-025-00229-xopenalex-snapshot

Cell reprogramming: methods, mechanisms and applications

inferred← citeshttps://doi.org/10.1186/s40035-024-00437-6openalex-snapshot

Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease

inferred← citeshttps://doi.org/10.1186/s40478-024-01845-5openalex-snapshot

Organoids and chimeras: the hopeful fusion transforming traumatic brain injury research

inferred← citeshttps://doi.org/10.15283/ijsc23169openalex-snapshot

Stem Cell-Based Approaches in Parkinson's Disease Research

inferred← citeshttps://doi.org/10.1590/1414-431x2024e13482openalex-snapshot

Revealing induced pluripotent stem cells' potential as a better alternative to embryonic stem cells for Parkinson's disease treatment based on single-cell RNA-seq

inferred← citeshttps://doi.org/10.1631/bdm.2400519openalex-snapshot

Research insights and clinical opportunities of functional organoid-based platforms

inferred← citeshttps://doi.org/10.2142/biophysico.bppb-v21.0023openalex-snapshot

Inducing aggresome and stable tau aggregation in Neuro2a cells with an optogenetic tool

inferred← citeshttps://doi.org/10.2174/0113894501395776250903093531openalex-snapshot

Novel Glitazones Protect Rotenone-induced Parkinsonism in Mouse Models by Targeting PGC1α

inferred← citeshttps://doi.org/10.3389/fncel.2023.1326279openalex-snapshot

Genetically encoded mediators for sonogenetics and their applications in neuromodulation

inferred← citeshttps://doi.org/10.3389/fncel.2024.1419526openalex-snapshot

Limitations of human brain organoids to study neurodegenerative diseases: a manual to survive

inferred← citeshttps://doi.org/10.3389/fnins.2026.1764964openalex-snapshot

Brain organoids as precision models for neurodegenerative diseases: from disease modeling to drug discovery

inferred← citeshttps://doi.org/10.3389/fphar.2025.1552741openalex-snapshot

CRISPR/Cas9 technology in tumor research and drug development application progress and future prospects

inferred← citeshttps://doi.org/10.3390/cells14050347openalex-snapshot

Age-Related Neurodegenerative Diseases: A Stem Cell’s Perspective

inferred← citeshttps://doi.org/10.3390/cells14080619openalex-snapshot

Induced Pluripotent Stem Cells-Based Regenerative Therapies in Treating Human Aging-Related Functional Decline and Diseases

inferred← citeshttps://doi.org/10.3390/cells15090839openalex-snapshot

Limitations of Stem Cell Therapy for Parkinson’s Disease

inferred← citeshttps://doi.org/10.3390/cells15191768openalex-snapshot

Human iPSC-Derived Brain Cells, Organoids, and Organoids-on-Chips: Advancing Neurological Disease Modeling to Improve Clinical Outcome

inferred← citeshttps://doi.org/10.3390/ijms25052680openalex-snapshot

Application Prospect of Induced Pluripotent Stem Cells in Organoids and Cell Therapy

inferred← citeshttps://doi.org/10.3390/ijms27083371openalex-snapshot

CRISPR Applications in Alzheimer’s Disease: From High-Throughput Genetic Screening to Precision Editing and CNS Delivery

inferred← citeshttps://doi.org/10.4103/nrr.nrr-d-24-00771openalex-snapshot

Induced pluripotent stem cell–related approaches to generate dopaminergic neurons for Parkinson’s disease

inferred← citeshttps://doi.org/10.4103/nrr.nrr-d-25-00924openalex-snapshot

Organoids: Key advances, optimization, and technological iterations in their application to neurodegenerative diseases

inferred← citeshttps://doi.org/10.4252/wjsc.v17.i9.109330openalex-snapshot

Exercise combined with induced pluripotent stem cells enhances the Wnt1-Lmx1a loop in the midbrain of Parkinsonian mice to alleviate Parkinsonian symptoms

inferred← citeshttps://doi.org/10.64898/2026.05.22.726943openalex-snapshot

Inter-organ communication shapes human metabolic tissue states and resolves anti-diabetic drug response modes in a six-tissue microphysiological system

inferred← citeshttps://doi.org/10.70675/44c2147bz67e5z4e37z925az38c78f1151c4openalex-snapshot

Rôles de FOXO3 dans la réponse cellulaire au stress et la neurodégénérescence au cours de la maladie Parkinson

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.